Videos

Want to find out the steps to deliver and sustain Lean on the shopfloor? In this presentation: change on the shopfloor, how to make change on the shopfloor happen and how to implement a management infrastructure to sustain the change. Presented by Dermot O'Rourke, Operational Excellence Manager, Pfizer at IQPC's OPEX conference in... view now

View this presentation to find out about integrating human factors engineering into medical devices to make them safe, effective and efficient to use, and the regulations for the human factors engineering process. Presented by Dr. Edmond W. Israelski, Human Factors Program Manager, Abbott Laboratories, at... view now

View this presentation to find out about co-crystals as novel forms, new intellectual property and patenting pure enantiomers and racemic forms. Presented by Jeffrey A. Lindeman Esq, Partner, Nixon Peabody LLP, at Developing IP Strategies for Crystalline Forms in November 2008.... view now

Want to design and implement effective patent strategies for co-crystal patents? In this presentation, decisions suggesting how US courts may view co-crystal patents, including analysis of Abbott v. Sandoz (Fed. Cir. 2009),  Sanofi-Synthelabo v. Apotex (Fed. Cir . 2008), and Pfizer v. Apotex (Fed. Cir. 2007). ... view now

View this presentation to find out more about crystallisation automation tools and processes, the use of solubility curves within development and the importance of polymorphism control. Presented by Dr. Jules Dickens, Principal Scientist, Johnson and Johnson at IQPC's Polymorphism and Crystallisation in May 2009.... view now

Want to find out more about rational guidelines for co-crystal synthesis via robust hydrogen bonding and crystal engineering of binary and ternary co-crystals and their phase behaviour? Read this presentation to gain from industry case studies of co-crystals’ structure-property relationships. Presented by Professor Ashwini... view now

In this case study: Driving the project as a joint venture between the Legal and IT teams, containing escalating storage capacity by applying automatic deletion rules, reducing e-discovery costs through enforcing the policy systematically, constructing a policy that enables... view now

Want to discover how mitochondrial impairment provides a novel model of idiosyncratic drug toxicity in accord with current risk factors?  Read this presentation to uncover a suite of assays which has been developed to detect drug-induced ‘off target’ mitochondrial dysfunction and apply... view now

View this presentation to find out more about production and manipulation of amorphous drugs by milling and co-milling, and purposely selecting the amorphous phase for development due to improved properties. Presented by Professor Marc Decamps, Therapeutic Materials Group, University of Lille, at IQPC's  Polymorphism and... view now

View this presentation to find out more about differentiating toxicology formulations from clinical formulations, assessing various approaches to handle changes in formulations and incorporating ADME/PK into your programme. Presented by Dr. Mitchell Friedman, Director of Toxicology, Takeda Pharmaceuticals, at IQPC's Predictive Toxicology conference.... view now